{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T11:33:26Z","timestamp":1771846406553,"version":"3.50.1"},"reference-count":36,"publisher":"Informa Healthcare","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2000,4]]},"DOI":"10.1517\/13543784.9.4.859","type":"journal-article","created":{"date-parts":[[2005,5,4]],"date-time":"2005-05-04T14:59:02Z","timestamp":1115218742000},"page":"859-870","source":"Crossref","is-referenced-by-count":3,"title":["Nicaraven for the treatment of cerebral vasospasm in subarachnoid haemorrhage"],"prefix":"10.1517","volume":"9","author":[{"given":"Kewal K","family":"Jain","sequence":"first","affiliation":[{"name":"Jain PharmaBiotech, Bl\u00e4siring 7, CH-4057 Basel, Switzerland. jain@pharmabiotech.ch"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2005,2,24]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006989222744"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.29.3.683"},{"key":"CIT0006","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.4.876"},{"key":"CIT0007","author":"JAIN KK","year":"1998","journal-title":"D&MD\/International Business Communications, Southborough, Massachusetts, USA"},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1007\/BF01401822"},{"key":"CIT0012","doi-asserted-by":"publisher","DOI":"10.1227\/00006123-199203000-00008"},{"key":"CIT0013","doi-asserted-by":"publisher","DOI":"10.2176\/nmc.38.704"},{"key":"CIT0014","first-page":"1011","volume":"90","author":"LANZINO G","year":"1999","journal-title":"Part I. A cooperative study in Europe, Australia, New Zealand and South Africa. J. Neurosurg."},{"key":"CIT0015","first-page":"1018","volume":"90","author":"LANZINO G","year":"1999","journal-title":"Part II. A cooperative study in North America. J. Neurosurg."},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.30.4.867"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.25.4.864"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1998.88.6.1082"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-199706000-00026"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.30.7.1409"},{"key":"CIT0021","first-page":"12","volume":"29","author":"YAMAGUCHI T","year":"1998","journal-title":"Ebselen Study Group. Stroke"},{"key":"CIT0022","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1080\/01616412.1997.11740859","volume":"19","author":"WATANABE T","year":"1997","journal-title":"Neurol. Res."},{"key":"CIT0023","first-page":"269","volume":"42","author":"SAITO I","year":"1998","journal-title":"SANO K eta].: Neuroprotective effect of an antioxidant, ebselen, in patients with delayed neurological deficits after aneurysmal subarachnoid hemorrhage. Neurosurgery"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1992.77.5.0763"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1998.88.2.0298"},{"key":"CIT0026","unstructured":"JAIN KK: Textbook of Gene Therapy. Hogrefe & Huber, Gottingen-Seattle, (1998b)."},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1016\/S1054-3589(08)60976-X"},{"key":"CIT0028","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5849(96)00629-6"},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(95)00764-Z"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-199702000-00027"},{"key":"CIT0032","doi-asserted-by":"publisher","DOI":"10.1016\/0168-0102(95)00936-N"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199610270-00012"},{"key":"CIT0034","first-page":"105","volume":"71","author":"KAMADA K","year":"1996","journal-title":"Hokkaido Igaku Zasshi"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1986.tb12952.x"},{"key":"CIT0037","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(95)70201-6"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1097\/00002826-199901000-00003"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006855917392"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-0102(98)00052-2"},{"key":"CIT0042","first-page":"764","volume":"34","author":"MIZUKAMI M","year":"1984","journal-title":"Arzneimittelfor-schung"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1998.88.6.1075"},{"key":"CIT0045","first-page":"429","volume":"48","author":"ISHIGAI M","year":"1998","journal-title":"Arzneimittelforschung"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1996.84.5.0792"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/13543784.9.4.859","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T12:42:06Z","timestamp":1536237726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/13543784.9.4.859"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,4]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2005,2,24]]},"published-print":{"date-parts":[[2000,4]]}},"alternative-id":["10.1517\/13543784.9.4.859"],"URL":"https:\/\/doi.org\/10.1517\/13543784.9.4.859","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,4]]}}}